Mirador Therapeutics, a company focused on developing precision medicines for immune diseases, has successfully raised $250 million in a Series B financing round. This significant investment...
A new MIT spinout, Cache DNA, is transforming the way biomolecules are stored by developing technologies that eliminate the reliance on refrigeration. Founded by James Banal...
